Company

Antibody Therapeutics Inc., a JHBP company is a biopharmaceutical organization focused on the development of next generation therapeutic antibodies that improve patients’ lives. The company was co-founded in 2019 in the San Francisco Bay Area as a spin-off from Antibody Studio Inc.

With a strong leadership team, Antibody Therapeutics is governed by highly accomplished experts in the drug development field with proven track records.

Our company incorporates Genor Biopharma’s, a JHBP company, unique CMC, Clinical Development experience and Antibody Studio's unique platform technology.....

Team

Antibody Therapeutics has a group of dynamic and passionate scientists coming from well-known big pharma and academia. Our leadership team is comprised of highly accomplished experts in the drug development field with proven track records. We work together to translate immunotherapy to alleviate the burden of patients suffering from severe diseases. With different academic, social, cultural backgrounds and limited resources, we are serious about what we do. Our culture continues to be built every day through the actions of our team.

Visions and Values

The vision of Antibody Therapeutics revolves around creating life-changing next generation Multi-specific Therapeutic Antibodies for patients with severe diseases. Our core values reflect the most important aspects of being a scientist, and patients’ well-being is central to our concept.